Final Fantasy game developer Square Enix has announced auction dates for its upcoming Symbiogenesis nonfungible tokens (NFTs). In a Nov. 24 social media post, the team said it would sell the NFTs in three batches. The first batch will be auctioned from Nov. 27 to 28, the second from Nov. 30 to Dec. 4, and the third from Dec. 2 to 3. Symbiogenesis is Square Enix’s upcoming blockchain game that features Ethereum-based NFTs.
Starting next week, it's finally time for the start of the auction!
— SYMBIOGENESIS -NFT Art＆Game Project- | SQUARE ENIX (@symbiogenesisPR) November 24, 2023
Phase 1: 11/27 12:00 - 11/28 11:59 (JST)
Phase 2: 11/30 12:00 - 12/1 11:59 (JST)
Phase 3: 12/2 12:00 - 12/3 11:59 (JST)
More details herehttps://t.co/MFprrApwio#SYMBIOGENESIS
According to the game’s documents, the first phase will include facet and mesh characters and will only allow “stakeholders” to participate. This seems to imply that only early investors will be able to participate in the Nov. 27–28 phase. The second and third phases will be available to participants in an “allowlist entry campaign,” the documents state.
The game’s team ran the allowlist entry campaign from Nov. 7 to 21. Collectors were asked to participate in a series of quizzes, as well as a “treasure hunt” that took place within a prototype version of the Symbiogenesis game world.
The participants earned NFT “relics” as a result of these activities, and they scored points toward participating in phase 2. The top 50 highest scores will be allowed to acquire NFTs in phase 2, as well as 40 random participants ranked 51st to 300th. The rest of the participants will be allowed to bid on items in phase 3.
Square Enix describes Symbiogenesis as a “narrative-unlocked NFT entertainment” game. It is scheduled to be launched on Dec 21.
Square Enix is the creator of the Final Fantasy series of games, which the company claims has sold over 173 million units. It launched Final Fantasy NFT trading cards on March 31. In April, the company announced it was partnering with Web3 infrastructure provider Elixir, although details of the partnership have been scarce.
